Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
9.15
-0.07 (-0.76%)
At close: Jul 2, 2026, 4:00 PM EDT
9.20
+0.05 (0.55%)
After-hours: Jul 2, 2026, 7:58 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $54.74 million as of July 2, 2026. Its market cap has increased by 58.95% in one year.
Market Cap
54.74M
Enterprise Value
-88.95M
1-Year Change
58.95%
Ranking
Category
Stock Price
$9.15
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $54.74M, a decrease of -87.17%. That is a compound annual growth rate of -35.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 54.74M | 62.87% |
| Dec 31, 2025 | 33.61M | -19.94% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiNK Therapeutics | 58.14M |
| aTyr Pharma | 58.10M |
| Immutep | 57.21M |
| Boundless Bio | 56.16M |
| Mereo BioPharma Group | 53.42M |
| Instil Bio | 52.42M |
| Radiopharm Theranostics | 51.60M |
| Veraxa Biotech AG | 51.44M |